Kamil Witkowski is a skilled health economics and outcomes research (HEOR) professional with over 10 years of experience in global health technology assessment (HTA) submissions. Currently serving as the Global HEOR Modelling Lead at Sanofi, Kamil is responsible for strategic market access, real-world evidence generation, and enhancing patient access to therapies in rare diseases and oncology. Kamil has previously held roles at Creativ-Ceutical, Novartis, and as an independent consultant, specializing in cost-utility model development and health economic modeling. Kamil also has a background in biochemistry from University College London and is pursuing a Master’s degree in Health Economics at the University of York.
This person is not in the org chart
This person is not in any teams
This person is not in any offices